Literature DB >> 17503134

Neuropsychiatric syndromes associated with multiple sclerosis.

Anthony Feinstein1.   

Abstract

Multiple sclerosis is associated with diverse behavioral changes. Rates of major depression approach 50% over the course of patients' lives, rates of bipolar disorder and psychosis are twice as common when compared to rates in the general population and pseudobulbar affect will afflict one in ten patients. However, these disorders often respond well to pharmacologic treatment and in the case of major depression, some forms of psychotherapy too. This article summarizes these mental state changes, their pathogenesis and treatment. Correct diagnosis and treatment can substantially improve the quality of life for MS patients.

Entities:  

Mesh:

Year:  2007        PMID: 17503134     DOI: 10.1007/s00415-007-2017-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Pure neuropsychiatric presentation of multiple sclerosis.

Authors:  Ali A Asghar-Ali; Katherine H Taber; Robin A Hurley; L Anne Hayman
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

2.  Effect of fluoxetine on patients with multiple sclerosis.

Authors:  J W Flax; J Gray; J Herbert
Journal:  Am J Psychiatry       Date:  1991-11       Impact factor: 18.112

3.  Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex.

Authors:  A Feinstein; P O'Connor; T Gray; K Feinstein
Journal:  Mult Scler       Date:  1999-04       Impact factor: 6.312

Review 4.  Multiple sclerosis, disease modifying treatments and depression: a critical methodological review.

Authors:  A Feinstein
Journal:  Mult Scler       Date:  2000-10       Impact factor: 6.312

5.  Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis.

Authors:  J Pujol; J Bello; J Deus; J L Martí-Vilalta; A Capdevila
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

6.  An examination of suicidal intent in patients with multiple sclerosis.

Authors:  Anthony Feinstein
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

7.  Increased depression in multiple sclerosis patients. A meta-analysis.

Authors:  D S Schubert; R H Foliart
Journal:  Psychosomatics       Date:  1993 Mar-Apr       Impact factor: 2.386

8.  Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis.

Authors:  R H B Benedict; I Fishman; M M McClellan; R Bakshi; B Weinstock-Guttman
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

9.  Treatment of pathologic laughing and weeping with amitriptyline.

Authors:  R B Schiffer; R M Herndon; R A Rudick
Journal:  N Engl J Med       Date:  1985-06-06       Impact factor: 91.245

10.  Structural brain abnormalities in multiple sclerosis patients with major depression.

Authors:  A Feinstein; P Roy; N Lobaugh; K Feinstein; P O'Connor; S Black
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

View more
  15 in total

1.  Neuropsychiatric manifestations of multiple sclerosis.

Authors:  Laura C Politte; Jeff C Huffman; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

2.  Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.

Authors:  Philip Brenner; Ellenor Mittendorfer-Rutz; Jussi Jokinen; Kristina Alexanderson; Jan Hillert; Petter Tinghög
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-05-11       Impact factor: 4.328

3.  Psychotic reaction as a manifestation of multiple sclerosis relapse treated with plasma exchange.

Authors:  Tereza Gabelić; Ivan Adamec; Anamarija Mrđen; Milan Radoš; Vesna V Brinar; Mario Habek
Journal:  Neurol Sci       Date:  2011-07-28       Impact factor: 3.307

4.  Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats.

Authors:  Justin R Gregg; Nicole R Herring; Alipi V Naydenov; Ryan P Hanlin; Christine Konradi
Journal:  Schizophr Res       Date:  2009-07-01       Impact factor: 4.939

5.  Relationship Between Anxiety and Cognition in Multiple Sclerosis: Implications for Treatment.

Authors:  Nicholas A Vissicchio; Caroline Altaras; Amanda Parker; Shonna Schneider; Jeffrey G Portnoy; Roseanne Archetti; Marnina Stimmel; Frederick W Foley
Journal:  Int J MS Care       Date:  2019 Jul-Aug

Review 6.  Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.

Authors:  Giulia Menculini; Elena Chipi; Federico Paolini Paoletti; Lorenzo Gaetani; Pasquale Nigro; Simone Simoni; Andrea Mancini; Nicola Tambasco; Massimiliano Di Filippo; Alfonso Tortorella; Lucilla Parnetti
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

7.  White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia.

Authors:  Haiyun Xu; Xin-Min Li
Journal:  Schizophr Res Treatment       Date:  2011-08-11

8.  Antidepressant activity of fingolimod in mice.

Authors:  Luigi di Nuzzo; Rosamaria Orlando; Cristina Tognoli; Paola Di Pietro; Giuseppe Bertini; Jessica Miele; Domenico Bucci; Marta Motolese; Sergio Scaccianoce; Alessandra Caruso; Gianluca Mauro; Carmine De Lucia; Giuseppe Battaglia; Valeria Bruno; Paolo Francesco Fabene; Ferdinando Nicoletti
Journal:  Pharmacol Res Perspect       Date:  2015-05-24

9.  Depressive symptoms in multiple sclerosis from an in vivo study with TBSS.

Authors:  Yujuan Shen; Lijun Bai; Ying Gao; Fangyuan Cui; Zhongjian Tan; Yin Tao; Chuanzhu Sun; Li Zhou
Journal:  Biomed Res Int       Date:  2014-05-04       Impact factor: 3.411

Review 10.  The epidemiologic evidence linking autoimmune diseases and psychosis.

Authors:  Michael E Benros; William W Eaton; Preben B Mortensen
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.